טוען...
Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease
AIM: The aim of the study was to assess ticagrelor's effects on inhibition of platelet aggregation (IPA), P2Y(12) reaction units (PRU, measure of platelet P2Y(12) receptor blockade), pharmacokinetic (PK) parameters and safety in Chinese patients with stable coronary artery disease (CAD). METHOD...
שמור ב:
| הוצא לאור ב: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972151/ https://ncbi.nlm.nih.gov/pubmed/27038001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12950 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|